BR0212927A - Formas pseudopolimórficas de carvedilol - Google Patents
Formas pseudopolimórficas de carvedilolInfo
- Publication number
- BR0212927A BR0212927A BR0212927-2A BR0212927A BR0212927A BR 0212927 A BR0212927 A BR 0212927A BR 0212927 A BR0212927 A BR 0212927A BR 0212927 A BR0212927 A BR 0212927A
- Authority
- BR
- Brazil
- Prior art keywords
- carvedilol
- forms
- pseudopolymorphic forms
- pseudopolymorphic
- pseudopolimorphic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"FORMAS PSEUDOPOLIMóRFICAS DE CARVEDILOL". A presente invenção refere-se a formas pseudopolimórficas de (<sym>) 1-(4-carbazolilóxi)-3-[2-metoxifenóxi) etilamino]-2-propanol (carvedilol) ou de formas opticamente ativas de sais farmaceuticamente aceitáveis do mesmo, aos processos para a preparação dos mesmos e a composições farmacêuticas que contêm as mesmas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01123422 | 2001-09-28 | ||
PCT/EP2002/010451 WO2003029214A1 (en) | 2001-09-28 | 2002-09-18 | Pseudopolymorphic forms of carvedilol |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212927A true BR0212927A (pt) | 2004-10-13 |
Family
ID=8178782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0212927-2A BR0212927A (pt) | 2001-09-28 | 2002-09-18 | Formas pseudopolimórficas de carvedilol |
Country Status (20)
Country | Link |
---|---|
US (3) | US20030119893A1 (pt) |
EP (1) | EP1432681B1 (pt) |
JP (1) | JP2005507899A (pt) |
KR (1) | KR100752549B1 (pt) |
CN (1) | CN1308307C (pt) |
AR (1) | AR036689A1 (pt) |
AT (1) | ATE369339T1 (pt) |
AU (1) | AU2002338726B2 (pt) |
BR (1) | BR0212927A (pt) |
CA (1) | CA2460486A1 (pt) |
DE (1) | DE60221683T2 (pt) |
ES (1) | ES2291503T3 (pt) |
GT (1) | GT200200198A (pt) |
MX (1) | MXPA04002826A (pt) |
PA (1) | PA8555201A1 (pt) |
PE (1) | PE20030448A1 (pt) |
PL (1) | PL370412A1 (pt) |
RU (1) | RU2308449C2 (pt) |
UY (1) | UY27461A1 (pt) |
WO (1) | WO2003029214A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1245974C (zh) * | 2000-06-28 | 2006-03-22 | 特瓦制药工业有限公司 | 卡维地洛 |
PL371409A1 (en) | 2002-01-15 | 2005-06-13 | Teva Pharmaceutical Industries Ltd. | Crystalline solids of carvedilol and processes for their preparation |
KR20140006111A (ko) | 2002-06-27 | 2014-01-15 | 스미스클라인 비이참 (코르크) 리미티드 | 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법 |
SI21616A (sl) * | 2003-09-02 | 2005-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove kristalne oblike karvedilola |
KR20070088507A (ko) * | 2005-06-09 | 2007-08-29 | 테바 파마슈티컬 인더스트리즈 리미티드 | 카베딜올의 결정질 형태 및 이것의 제조 방법 |
WO2008002683A2 (en) * | 2006-06-28 | 2008-01-03 | Teva Pharmaceutical Industries Ltd. | Polymorphous forms of carvedilol phosphate |
US20090028935A1 (en) * | 2006-12-01 | 2009-01-29 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
US20080292695A1 (en) * | 2006-12-01 | 2008-11-27 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
WO2008105794A1 (en) * | 2007-02-26 | 2008-09-04 | Teva Pharmaceutical Industries Ltd. | Process for the purification of carvedilol or its salts thereof |
US20080249317A1 (en) * | 2007-04-04 | 2008-10-09 | Apotex Inc. | Novel amorphous form of carvedilol phosphate and processes for the preparation thereof |
TWI415604B (zh) | 2009-09-29 | 2013-11-21 | Tsh Biopharm Corp Ltd | 調控釋放卡菲蒂羅劑型 |
US20110229564A1 (en) * | 2010-03-22 | 2011-09-22 | Amneal Pharmaceuticals, L.L.C. | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
US5393772A (en) * | 1993-11-24 | 1995-02-28 | Boehringer Mannheim Pharmaceuticals Corporation | Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation |
EP0893440A1 (en) * | 1997-07-22 | 1999-01-27 | Roche Diagnostics GmbH | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
US20010036959A1 (en) * | 2000-04-03 | 2001-11-01 | Gabel Rolf Dieter | Carvedilol-hydrophilic solutions |
CN1245974C (zh) * | 2000-06-28 | 2006-03-22 | 特瓦制药工业有限公司 | 卡维地洛 |
-
2002
- 2002-09-18 AU AU2002338726A patent/AU2002338726B2/en not_active Ceased
- 2002-09-18 AT AT02777139T patent/ATE369339T1/de not_active IP Right Cessation
- 2002-09-18 CN CNB028187415A patent/CN1308307C/zh not_active Expired - Fee Related
- 2002-09-18 EP EP02777139A patent/EP1432681B1/en not_active Expired - Lifetime
- 2002-09-18 JP JP2003532464A patent/JP2005507899A/ja active Pending
- 2002-09-18 MX MXPA04002826A patent/MXPA04002826A/es active IP Right Grant
- 2002-09-18 BR BR0212927-2A patent/BR0212927A/pt not_active IP Right Cessation
- 2002-09-18 RU RU2004113209/04A patent/RU2308449C2/ru not_active IP Right Cessation
- 2002-09-18 PL PL02370412A patent/PL370412A1/xx not_active Application Discontinuation
- 2002-09-18 CA CA002460486A patent/CA2460486A1/en not_active Abandoned
- 2002-09-18 KR KR1020047004578A patent/KR100752549B1/ko not_active IP Right Cessation
- 2002-09-18 DE DE60221683T patent/DE60221683T2/de not_active Expired - Fee Related
- 2002-09-18 ES ES02777139T patent/ES2291503T3/es not_active Expired - Lifetime
- 2002-09-18 WO PCT/EP2002/010451 patent/WO2003029214A1/en active IP Right Grant
- 2002-09-24 PE PE2002000938A patent/PE20030448A1/es not_active Application Discontinuation
- 2002-09-25 PA PA20028555201A patent/PA8555201A1/es unknown
- 2002-09-26 US US10/255,290 patent/US20030119893A1/en not_active Abandoned
- 2002-09-27 AR ARP020103656A patent/AR036689A1/es not_active Application Discontinuation
- 2002-09-27 UY UY27461A patent/UY27461A1/es not_active Application Discontinuation
- 2002-09-27 GT GT200200198A patent/GT200200198A/es unknown
-
2004
- 2004-04-20 US US10/827,859 patent/US20040198812A1/en not_active Abandoned
-
2006
- 2006-01-05 US US11/325,754 patent/US20060148878A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002338726B9 (en) | 2003-04-14 |
AR036689A1 (es) | 2004-09-29 |
PL370412A1 (en) | 2005-05-30 |
MXPA04002826A (es) | 2004-07-02 |
DE60221683T2 (de) | 2008-04-30 |
UY27461A1 (es) | 2003-06-30 |
WO2003029214A1 (en) | 2003-04-10 |
PE20030448A1 (es) | 2003-06-19 |
KR20040047872A (ko) | 2004-06-05 |
CN1308307C (zh) | 2007-04-04 |
DE60221683D1 (en) | 2007-09-20 |
EP1432681A1 (en) | 2004-06-30 |
GT200200198A (es) | 2003-06-19 |
US20030119893A1 (en) | 2003-06-26 |
US20040198812A1 (en) | 2004-10-07 |
RU2308449C2 (ru) | 2007-10-20 |
KR100752549B1 (ko) | 2007-08-30 |
PA8555201A1 (es) | 2003-12-10 |
AU2002338726B2 (en) | 2007-03-15 |
CN1558900A (zh) | 2004-12-29 |
CA2460486A1 (en) | 2003-04-10 |
JP2005507899A (ja) | 2005-03-24 |
ATE369339T1 (de) | 2007-08-15 |
ES2291503T3 (es) | 2008-03-01 |
RU2004113209A (ru) | 2005-05-20 |
US20060148878A1 (en) | 2006-07-06 |
EP1432681B1 (en) | 2007-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2195366T3 (es) | Modificacion termodinamicamente estable de 1-(4-carbazoliloxi)-4-(2-(2-metoxifenoxi)etillamino)-2-propanol, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
BR0212927A (pt) | Formas pseudopolimórficas de carvedilol | |
CY1107294T1 (el) | Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες | |
HUP0203056A1 (hu) | Vakcinakészítmény | |
CY1117639T1 (el) | Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης | |
BR9902086A (pt) | Formulações farmacêuticas. | |
BRPI0409068A (pt) | composições farmacêuticas para inibidores de protease viral de hepatite c. | |
ECSP045300A (es) | Antígenos virales | |
CY1106468T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
EA200401526A1 (ru) | Новые соединения и их применение | |
BR0211807A (pt) | Derivados ativos amino-ftalazinona como inibidores de cinase, processo para sua preparação e composições farmacêuticas para os mesmos | |
ATE455092T1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
BR9917007A (pt) | Moduladores de ccr5 | |
NO20092274L (no) | Ansamycinformuleringer og fremgangsmater for anvendelse derav | |
BR0207640A (pt) | Composição farmacêutica oral de cefpodoxima proxetil | |
CY1111567T1 (el) | Ενδιαμεσα διβενζο (b,f) αζεπινης | |
BR0212386A (pt) | Composto, formulação farmacêutica, e, uso de um composto | |
HUP9904092A2 (hu) | Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására | |
BRPI0411998A (pt) | moduladores delta-opióides tricìclicos | |
BR0311984A (pt) | Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
BRPI0513075A (pt) | moduladores gama-opióides tricìclicos | |
BR0317284A (pt) | Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno | |
BR0208504A (pt) | Composição farmacêutica estável de pravastatina | |
BR0308201A (pt) | Derivados de quinolina | |
ATE328595T1 (de) | Carvedilolpolymorph |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |